GLP-1R agonists’ type 2 diabetes and obesity market to reach $125 billion in 7MM by 2033: GlobalData Read more
Glenmark receives ANDA approval for Brimonidine Tartrate and Timolol Maleate Ophthalmic Solution, 0.2%|0.5% Read more
Growth Guardian I Sanjaya Mariwala, Executive Chairman and Managing Director, OmniActive Health Technologies Read more